Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing
Go back to Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing| Genentech, Inc. (NYSE: DNA) | Delayed: 11.74 -1.26 (9.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.00 | 52 Week High | $99.14 | |||
| Open | $12.69 | 52 Week Low | $69.17 | |||
| Day High | $12.82 | P/E | 3.66 | |||
| Day Low | $11.26 | EPS | $3.21 | |||
| Volume | 2,291,847 | |||||



